GlassScriptPhysician profile
Mazen Hadid
NPI 1477704252
$8,643.66
in general payments reported to CMS, 2019-2025
33 companies · $500 in 2025
The $500 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,143 · 2020: $360 · 2021: $806 · 2022: $100 · 2023: $1,472 · 2024: $263 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,135 · Food and Beverage: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,134.61 |
| Food and Beverage | $1,100.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,072.46 | 2019-2025 | Triclip |
| W. L. Gore & Associates, INC. | $1,283.04 | 2023 | Gore Cardioform Septal Occluder |
| Abiomed | $732.24 | 2019-2025 | Impella |
| Penumbra, INC. | $472.16 | 2019 | |
| Medtronic, INC. | $428.95 | 2021-2025 | Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $287.95 | 2019-2024 | Xarelto |
| Amgen INC. | $267.48 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $258.98 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $241.12 | 2019-2025 | Lifevest |
| Amarin Pharma, INC. | $212.05 | 2019-2020 | |
| Medtronic Vascular, INC. | $172.23 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.30 | 2020-2022 | |
| Zoll Medical Corporation | $145.83 | 2019 | |
| Kestra Medical Technology Services, INC. | $143.55 | 2024 | Assure Wcd |
| Surmodics, INC. | $130.01 | 2023-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access Guide Sheath, Sublime Microcatheter, 018, 200cm, Straight |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $99.41 | 2025 | Clottriever Bold Catheter, Artix Mt |
| Sanofi-Aventis U.S. LLC | $89.60 | 2019 | |
| Pfizer INC. | $60.22 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $51.16 | 2019-2020 | |
| Terumo Medical Corporation | $46.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $42.04 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $30.66 | 2019 | |
| Boston Scientific Corporation | $26.97 | 2021 | |
| Cordis US Corp. | $23.42 | 2022 | |
| Resmed Corp | $21.77 | 2019 | |
| Astellas Pharma US INC | $21.35 | 2019 | |
| Cardinal Health 200 LLC | $19.91 | 2020 | |
| Infobionic, INC | $19.39 | 2020 | |
| Ekos Corporation | $18.04 | 2019 | |
| Genzyme Corporation | $17.23 | 2019 | |
| Lantheus Medical Imaging, INC. | $15.91 | 2020 | |
| Lundbeck LLC | $15.42 | 2020 | |
| Teleflex LLC | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mazen Hadid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.